During the past decade, Jupiter Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 42 clinical trials were completed, i.e. on average, 420% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 10 clinical trials were completed. i.e. 1000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jupiter Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored and "Exact Sciences Corporation" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jupiter Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Jupiter Medical Center" are "Recurrent Breast Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Jupiter Medical Center" in a lesser frequency.

Most popular intervention types in "Jupiter Medical Center" are "Drug" (51 trials), "Other" (46 trials), "Biological" (25 trials), "Radiation" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (15 trials), "Paclitaxel" (14 trials), "Bevacizumab" (11 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Jupiter Medical Center" are 54 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jupiter Medical Center". undefined are not yet recruiting, 1 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Jupiter Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Jupiter Medical Center, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Jupiter Medical Center has several departments that took part in Clinical trials: "Ella Milbank Foshay Cancer Center at Jupiter Medical Center" - 60 trials